Role of Adjuvant Radiotherapy in Non-Small Cell Lung Cancer—A Review

Postoperative Radiation Therapy Should Be Used for Completely Resected Stage III-N2 NSCLC in Select Patients

(2022) Jason Liu et al.   Journal of Thoracic Oncology

Postoperative Radiation Therapy Should Not Be Used for the Therapy of Stage III-N2 NSCLC

(2022) Corinne Faivre-Finn et al.   Journal of Thoracic Oncology

Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non–small-cell Lung Cancer

(2021) David Boyce-Fappiano et al.   Clinical Lung Cancer

Radiation Therapy for Small-Cell Lung Cancer: ASCO Guideline Endorsement of an ASTRO Guideline

(2021) Megan E. Daly et al.   JOURNAL OF CLINICAL ONCOLOGY

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

(2021) David S. Ettinger et al.   Journal of the National Comprehensive Cancer Network

Intraoperative Lymph Node Management During Non-small Cell Lung Cancer Surgery

(2021) Michael R. Gooseman et al.   ANNALS OF SURGICAL ONCOLOGY

Preoperative and postoperative radiotherapy (RT) for non-small cell lung cancer: still an open question

(2021) Paul Van Houtte et al.   Translational Lung Cancer Research

Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy

(2021) J. Remon et al.   ANNALS OF ONCOLOGY

Role of Postoperative Radiotherapy in the Management for Resected NSCLC – Decision Criteria in Clinical Routine Pre- and Post-LungART

(2021) Krisztian Süveg et al.   Clinical Lung Cancer

Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial

(2021) Enriqueta Felip et al.   LANCET

Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non–Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy

(2021) Zhouguang Hui et al.   JAMA Oncology

Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial

(2021) Cecile Le Pechoux et al.   LANCET ONCOLOGY

Postoperative intensity‐modulated radiation therapy reduces local recurrence and improves overall survival in III‐N2 non‐small‐cell lung cancer: A single‐center, retrospective study

(2020) Wei Wei et al.   Cancer Medicine

Osimertinib as adjuvant therapy in patients (pts) with stage IB–IIIA EGFR mutation positive (EGFRm) NSCLC after complete tumor resection: ADAURA.

(2020) Roy S. Herbst et al.   JOURNAL OF CLINICAL ONCOLOGY

Complete Resection in Lung Cancer Surgery: From Definition to Validation and Beyond

(2020) Ramón Rami-Porta et al.   Journal of Thoracic Oncology

The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients

(2019) Yanqiu Zhang et al.   Biomed Research International

Lung cancer: diagnosis and management: summary of updated NICE guidance

(2019) Ross Maconachie et al.   BMJ-British Medical Journal

The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor (R) Descriptors for Non-Small Cell Lung Cancer

(2019) John G. Edwards et al.   Journal of Thoracic Oncology

Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study

(2019) Wan-Qin Zeng et al.   LUNG

Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base

(2018) Amy C. Moreno et al.   ANNALS OF SURGICAL ONCOLOGY

Quantitatively Excessive Normal Tissue Toxicity and Poor Target Coverage in Postoperative Lung Cancer Radiotherapy Meta-analysis

(2018) Yazan Abuodeh et al.   Clinical Lung Cancer

Male patients with resected IIIA-N2 non-small-cell lung cancer may benefit from postoperative radiotherapy: a population-based survival analysis

(2018) Peisi Kou et al.   Future Oncology

Sequencing of Postoperative Radiotherapy and Chemotherapy for Locally Advanced or Incompletely Resected Non–Small-Cell Lung Cancer

(2018) Samual Francis et al.   JOURNAL OF CLINICAL ONCOLOGY

Sequential Versus Concurrent Chemoradiation Therapy by Surgical Margin Status in Resected Non–Small Cell Lung Cancer

(2018) Vivek Verma et al.   Journal of the National Comprehensive Cancer Network

ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer

(2018) Ursula Nestle et al.   RADIOTHERAPY AND ONCOLOGY

Decision Making Criteria in Oncology

(2018) Markus Glatzer et al.   ONCOLOGY

The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer

(2018) Chongze Yuan et al.   JOURNAL OF SURGICAL ONCOLOGY

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial

(2017) Stephen G. Chun et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non–Small Cell Lung Cancer

(2017) Jong-Mu Sun et al.   Journal of Thoracic Oncology

Propensity score-matching analysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database

(2017) Shenhai Wei et al.   Radiation Oncology

Definitive radiochemotherapy versus surgery within multimodality treatment in stage III non-small cell lung cancer (NSCLC) - a cumulative meta-analysis of the randomized evidence

(2017) Christoph Pöttgen et al.   Oncotarget

Effect of postoperative radiotherapy on outcome in resectable stage IIIA-N2 non-small-cell lung cancer

(2017) Nazmus Sakib et al.   NUCLEAR MEDICINE COMMUNICATIONS

Postoperative radiotherapy for lung cancer: Is it worth the controversy?

(2016) Charlotte Billiet et al.   CANCER TREATMENT REVIEWS

Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target Volumes

(2016) Charlotte Billiet et al.   Journal of Thoracic Oncology

Reduced toxicity with three-dimensional conformal radiotherapy or intensity-modulated radiotherapy compared with conventional two-dimensional radiotherapy for esophageal squamous cell carcinoma: a secondary analysis of data from four prospective clinical

(2015) J.-Y. Deng et al.   DISEASES OF THE ESOPHAGUS

Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non–Small-Cell Lung Cancer

(2015) Elyn H. Wang et al.   JOURNAL OF CLINICAL ONCOLOGY

Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non–Small-Cell Lung Cancer Using the National Cancer Database

(2015) Christopher D. Corso et al.   Journal of Thoracic Oncology

Outcome of surgery versus radiotherapy after induction treatment in patients with N2 disease: systematic review and meta-analysis of randomised trials

(2015) P J McElnay et al.   THORAX

Selection of proper candidates with resected pathological stage IIIA-N2 non-small cell lung cancer for postoperative radiotherapy

(2015) Zhouguang Hui et al.   Thoracic Cancer

Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non–Small-Cell Lung Cancer

(2013) Damien Urban et al.   Journal of Thoracic Oncology

Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: An early closed randomized controlled trial

(2013) Wen-yi Shen et al.   RADIOTHERAPY AND ONCOLOGY

Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis

(2013) Charlotte Billiet et al.   RADIOTHERAPY AND ONCOLOGY

Role of Postoperative Radiotherapy in Resected Non-Small Cell Lung Cancer: A Reassessment Based on New Data

(2011) C. Le Pechoux   ONCOLOGIST

Epidemiology of Thymoma and Associated Malignancies

(2010) Eric A. Engels   Journal of Thoracic Oncology

Variations in Target Volume Definition for Postoperative Radiotherapy in Stage III Non–Small-Cell Lung Cancer: Analysis of an International Contouring Study

(2009) Femke O.B. Spoelstra et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Prognostic Factors for Resected Non-Small Cell Lung Cancer with pN2 Status: Implications for Use of Postoperative Radiotherapy

(2009) L. Moretti et al.   ONCOLOGIST

Impact of Postoperative Radiation Therapy on Survival in Patients With Complete Resection and Stage I, II, or IIIA Non–Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: The Adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial

(2008) Jean-Yves Douillard et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS